Skip to content

Castle Biosciences

US · CSTL #3242 by market cap Listed 2019
32.86 -0.55 -1.63%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/3/3
  • Rating change
    Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $52
    Market Newswire · 2026/5/7
  • Earnings Flash (CSTL) Castle Biosciences, Inc. Posts Q3 Adjusted Loss $0.13 per Share, Vs. FactSet Est of $-0.32
    MT Newswires · 2026/11/6
  • Canadian Investment Regulatory Organization Trading Halt - CSTL.P
    PR Newswire · 2026/11/10
  • Rating change
    Mizuho Securities Initiates Castle Biosciences(CSTL.US) With Buy Rating, Announces Target Price $60
    Market Newswire · 2026/10/29
  • BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $52
    Market Newswire · 2026/11/10
  • A Quick Look at Today's Ratings for Castle Biosciences(CSTL.US), With a Forecast Between $39 to $50
    Market Newswire · 2026/11/7
  • Rating change
    CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $40
    Market Newswire · 2026/4/20
  • KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $40
    Market Newswire · 2026/11/6
  • Rating change
    BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/5/13
  • Rating change
    Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $36
    Market Newswire · 2026/7/31
  • Rating change
    Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $43
    Market Newswire · 2026/5/7
  • Rating change
    Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $57
    Market Newswire · 2026/10/1
  • Rating change
    KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $35
    Market Newswire · 2026/5/29
  • Rating change
    Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $47
    Market Newswire · 2026/5/7
  • Rating change
    CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/8/3
  • Rating change
    Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $57
    Market Newswire · 2026/7/31
  • Rating change
    Roth MKM Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/9/22
  • Rating change
    BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Cuts Target Price to $40
    Market Newswire · 2026/5/13
  • Rating change
    BTIG Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44
    Market Newswire · 2026/8/3
  • Rating change
    Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $47
    Market Newswire · 2026/1/26
  • Rating change
    Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $52
    Market Newswire · 2026/1/14
  • Rating change
    KeyBanc Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/1/30
  • Rating change
    Guggenheim Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $43
    Market Newswire · 2026/1/5
  • Rating change
    Baird Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $44
    Market Newswire · 2026/2/27

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Castle Biosciences discussion 0 comments

Add a comment